2566937-60-6 ((Lisinopril impurity 2)

N2-((S)-1-Carboxy-3-phenylpropyl)-N6-(((S)-1-carboxy-3-phenylpropyl)-L-lysyl)-L-lysyl-L-proline;N5K5PZE63S;(2S)-1-[(2S)-6-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanamido]-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid;N6-[(N2-(1(S)-Carboxy-3-phenyl-propyl)-L-lysyl] Lisinopril;Lisinopril Dihydrate Impurity J [EP Impurity];2566937-60-6;Lisinopril impurity 2;

HNPFFJOLGHPMBR-XDIGFQIYSA-N

1S/C37H53N5O8/c38-23-9-7-16-28(40-30(35(45)46)21-19-26-12-3-1-4-13-26)33(43)39-24-10-8-17-29(34(44)42-25-11-18-32(42)37(49)50)41-31(36(47)48)22-20-27-14-5-2-6-15-27/h1-6,12-15,28-32,40-41H,7-11,16-25,38H2,(H,39,43)(H,45,46)(H,47,48)(H,49,50)/t28-,29-,30-,31-,32-/m0/s1

O=C([C@H](CCCCNC([C@H](CCCCN)N[C@H](C(=O)O)CCC1C=CC=CC=1)=O)N[C@H](C(=O)O)CCC1C=CC=CC=1)N1CCC[C@H]1C(=O)O